By expenditures
| Name | Title | Type |
|---|---|---|
| David, Yellott | Chief Financial Officer | Auditee |
| Tommy Naquin | PARTNER | Auditee |
| Tommy Naquin | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 337813 | 2024 | 2025-01-14 | Eisneramper | $1.62M |
| 11869 | 2023 | 2024-01-17 | Eisneramper LLP | $4.47M |
| 32378 | 2022 | 2023-02-08 | Postlewaite & Netterville | $1.79M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 337813 | 2024 | 2025-01-14 | 1095641 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 1095640 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 1095639 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 1095638 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 1095637 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 1095636 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 1095635 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 1095634 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 519199 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 519198 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 519197 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 519196 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 519195 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 519194 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 519193 | 2024-001 | Significant Deficiency | - | ILM |
| 337813 | 2024 | 2025-01-14 | 519192 | 2024-001 | Significant Deficiency | - | ILM |
| 11869 | 2023 | 2024-01-17 | 585166 | 2023-001 | Significant Deficiency | - | B |
| 11869 | 2023 | 2024-01-17 | 585165 | 2023-001 | Significant Deficiency | - | B |
| 11869 | 2023 | 2024-01-17 | 585164 | 2023-001 | Significant Deficiency | - | B |
| 11869 | 2023 | 2024-01-17 | 585163 | 2023-001 | Significant Deficiency | - | B |
| 11869 | 2023 | 2024-01-17 | 8724 | 2023-001 | Significant Deficiency | - | B |
| 11869 | 2023 | 2024-01-17 | 8723 | 2023-001 | Significant Deficiency | - | B |
| 11869 | 2023 | 2024-01-17 | 8722 | 2023-001 | Significant Deficiency | - | B |
| 11869 | 2023 | 2024-01-17 | 8721 | 2023-001 | Significant Deficiency | - | B |